TIPE2 Sensitizes Breast Cancer Cells to Paclitaxel by Suppressing Drug-Induced Autophagy and Cancer Stem Cell Properties

The in vitro and in vivo study demonstrated that tumor necrosis factor-α-induced protein-8-like-2 (TIPE2) sensitized breast cancer cells to paclitaxel by suppressing drug-induced autophagy and CSC properties.